almitrine--raubasine-drug-combination has been researched along with raubasine* in 3 studies
1 review(s) available for almitrine--raubasine-drug-combination and raubasine
| Article | Year |
|---|---|
Pathophysiology of postischemic hypoxia and cerebral protection: implications of the almitrine and raubasine combination.
Topics: Almitrine; Animals; Brain Ischemia; Drug Combinations; Hypoxia, Brain; Ischemic Attack, Transient; Neuroprotective Agents; Piperazines; Secologanin Tryptamine Alkaloids; Treatment Outcome; Yohimbine | 1995 |
1 trial(s) available for almitrine--raubasine-drug-combination and raubasine
| Article | Year |
|---|---|
[Comparison of the effects of almitrine, raubasine and 5023 SE on arterial oxygen desaturation during exercise].
The effects of almitrine (60 mg/24 h), raubasine (20 mg/24 h) and Duxil administered orally were compared in 30 elderly subjects (mean age: 60 years) who showed a decrease in oxygen saturation during maximum exercise. After 1 month of treatment, raubasine proved ineffective whereas almitrine and Duxil significantly reduced this decrease. The effect of Duxil was significantly more pronounced than that of almitrine. Topics: Almitrine; Arteries; Drug Combinations; Humans; Middle Aged; Oxygen; Physical Exertion; Piperazines; Secologanin Tryptamine Alkaloids; Yohimbine | 1983 |
1 other study(ies) available for almitrine--raubasine-drug-combination and raubasine
| Article | Year |
|---|---|
Cerebral ischemia: from pharmacology to modern techniques and clinical implications. Value of almitrine-raubasin (Duxil Duxaril). International symposium, Hangzhou, People's Republic of China, May 14, 1994.
Topics: Almitrine; Brain Ischemia; Drug Combinations; Humans; Neuroprotective Agents; Piperazines; Secologanin Tryptamine Alkaloids; Yohimbine | 1995 |